Butterfly Network Inc Dossier
Qualitative Analysis
Business overview
Butterfly Network, Inc. (NYSE: BFLY) is a digital health company driving a revolution in medical imaging with its proprietary semiconductor-based Ultrasound-on-Chip™ technology. The company's flagship handheld point-of-care ultrasound (POCUS) devices, including the Butterfly iQ, iQ+, and the third-generation iQ3, leverage Moore's Law to deliver affordable, high-performance, whole-body imaging directly to a smartphone, tablet, or hospital computer system. By combining advanced hardware with cloud-connected software, artificial intelligence (AI) tools like Compass AI™, and educational platforms, Butterfly aims to democratize medical imaging and improve clinical workflows globally.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Centralizing semiconductor co-development and chip licensing activities (formerly under the Octiv subsidiary) to license Butterfly's proprietary Ultrasound-on-Chip technology to third parties for non-competitive applications.
Expected impact: Serves as a long-term value driver, generating licensing revenue, future chip sales, and revenue-sharing opportunities.
An open AI application ecosystem and marketplace that allows third-party developers to build custom AI applications using Butterfly's Software Development Kit (SDK).
Expected impact: Accelerates the development of advanced AI-enabled image acquisition tools and drives broader clinical adoption of handheld ultrasound.
Deploying the next-generation Compass AI enterprise software to connect devices, workflows, and departments across large-scale healthcare systems.
Expected impact: Drives enterprise pipeline growth, supports account refreshes, and increases institutional adoption.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Midjourney's newly announced healthcare division, Midjourney Medical, unveiled the 'Midjourney Scanner'—a full-body ultrasonic computational tomography device that incorporates 40 of Butterfly's Ultrasound-on-Chip imaging modules per system.
Terms: Disclosed in a Form 8-K in November 2025, the agreement carries up to $74 million in expected payments to Butterfly over a five-year term.